Torrent Pharmaceuticals Ltd (TORNTPHARM)
Healthcare · Pharmaceuticals · NSE · Updated 1 October 2026
₹4,915.15↑ 36.51% (1Y)
🎯 Key Takeaways
- Revenue grew 17.3% QoQ to ₹4,921 in Q1FY27.
- Market Cap
- ₹1.87 L Cr
- P/E Ratio
- 78.4
- P/B Ratio
- 22.29
- ROE
- 25.7%
- ROCE
- 15.1%
- Debt/Equity
- 1.76
- Div Yield
- 0.77%
- Promoter
- 68.3%
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 3,302 | 3,303 | 4,197 | 4,921 |
| Operating Profit | 879 | 882 | 848 | 1,071 |
| OPM % | 26.6% | 26.7% | 20.2% | 21.8% |
| Net Profit | 591 | 635 | 364 | 566 |
| EPS | ₹17.54 | ₹18.77 | ₹11.51 | ₹14.87 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 169 | 169 | 169 | 169 |
| Reserves | 7,422 | 7,335 | 8,219 | 8,280 |
| Borrowings | 3,202 | 3,128 | 14,798 | 2,822 |
| Total Liabilities | 14,990 | 15,088 | 44,312 | 15,515 |
| Fixed Assets | 3,455 | 3,217 | 33,362 | 3,458 |
| Investments | 156 | 127 | 961 | 133 |
| Total Assets | 14,990 | 15,088 | 44,312 | 15,515 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2026 |
|---|---|
| Operating | +3,023 |
| Investing | -12,712 |
| Financing | +10,151 |
| Net Cash Flow | +461 |
👥 Shareholding Pattern
| Category | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
| Promoters | 68.3% | 68.3% | 68.3% |
| FII | 16.1% | 16.2% | 15.4% |
| DII | 9.2% | 9.1% | 9.8% |
| Public | 4.0% | 4.1% | 5.0% |
| # Shareholders | 76,214 | 83,811 | 85,776 |
⚖️ Peer Comparison — Pharmaceuticals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| SUNPHARMA | 4.46 L Cr | 36.9 | 18.7% | — | 0.05 |
| DIVISLAB | 2.52 L Cr | 86.0 | 23.0% | — | 0.00 |
| TORNTPHARM | 1.87 L Cr | 78.4 | 15.1% | — | 1.76 |
| ZYDUSLIFE | 1.19 L Cr | 26.6 | 16.8% | — | 0.43 |
| CIPLA | 1.12 L Cr | 33.1 | 13.2% | — | 0.01 |
| LAURUSLABS | 1.07 L Cr | 98.0 | 20.8% | — | 0.45 |
| MANKIND | 1.05 L Cr | 51.4 | 13.9% | — | 0.38 |
| DRREDDY | 1.04 L Cr | 32.3 | 10.1% | — | 0.17 |
| AUROPHARMA | 97,987 | 26.6 | 12.8% | — | 0.20 |
| LUPIN | 94,190 | 16.6 | 27.9% | — | 0.26 |
🔗 Peer Stock Analyses
📋 Recent Filings
- 🔴 Corporate Action2026-09-28Torrent Pharmaceuticals announced an amendment to its share subscription agreement with Torrent Urja 27 Private Limited to increase its investment fro…
- Announcement2026-09-28Torrent Pharmaceuticals announced that its designated persons' trading window closes on October 1, 2026, and remains shut until 48 hours after filing …
- 🔴 Announcement2026-09-10Torrent Pharmaceuticals announced its participation in multiple investor meetings scheduled between September 17 and 21, 2026, including group and one…
- 🟡 voting results2026-09-07Torrent Pharmaceuticals announced that shareholders approved the appointment of Shanti Ekambaram as an Independent Director with 99.98% of valid votes…
- 🟡 voting results2026-09-07Torrent Pharmaceuticals announced the outcome of its postal ballot vote on appointing Shanti Ekambaram as an Independent Director. Shareholders approv…
- Announcement2026-08-11Torrent Pharmaceuticals announced that NSE Sustainability Ratings and Analytics assigned the company an ESG rating of 70, reflecting its environmental…
- Announcement2026-08-11Torrent Pharmaceuticals announced its participation in an investors' meet hosted by Emkay on August 14, 2026, in Mumbai, as part of Regulation 30 comp…
- 🔴 Financial Results2026-08-04Torrent Pharmaceuticals announced a conference call transcript for Q1 FY26 results on August 4, 2026, inviting analysts and institutional investors to…
- 🟡 Board Meeting2026-08-01Torrent Pharmaceuticals announced the cessation of Ameera Shah as an Independent Director effective 01-Aug-2026, following completion of her term as p…
- 🔴 Financial Results2026-07-30Torrent Pharmaceuticals announced that the audio recording of its conference call discussing financial results for the quarter ended June 30, 2026, is…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when TORNTPHARM files new disclosures
Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track TORNTPHARM — FreeFree account · 2 AI queries/day